A new modified protocol of collagenase clostridium histolyticum (CCH) treatment for Peyronie's disease comprising only three instead of eight CCH injections was found to be safe and effective in a single-centre setting. In a cohort of men with mean penile curvature of 54° at baseline, 51 of 53 men had a mean improvement of 17.36° (31.4%). Only mild and transient local adverse events were observed.
References
Raheem, A. A. et al. Safety and effectiveness of collagenase clostridium histolyticum (CCH) (Xiapex®) in the treatment of Peyronie's disease using a new modified shortened protocol. BJU Int. http://dx.doi.org/10.1111/bju.13932 (2017)
Rights and permissions
About this article
Cite this article
Thoma, C. Shortened CCH treatment for Peyronie's disease. Nat Rev Urol 14, 516 (2017). https://doi.org/10.1038/nrurol.2017.107
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.107